via nytimes.com
One investor in Kadmon, who also sits on its board, said Mr. Waksal’s energy and his acumen in spotting promising drugs far outweigh his past problems.
“He is irrepressible,” said this investor, who spoke on the condition that she not be named because her company has a policy against being quoted in the media. “I don’t think what happened to Sam in the past is going to have a negative effect on my investment in this business.”
1 comment:
Sounds a little like the movie, Wall Street II.
Post a Comment